Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study
Open Access
- 20 September 2007
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 7 (1) , 179
- https://doi.org/10.1186/1471-2407-7-179
Abstract
Background: Feline mammary carcinoma has been proposed as a natural model of highly aggressive, hormone-independent human breast cancer. To further explore the utility of the model by adding new similarities between the two diseases, we have analyzed the oncogene HER-2 status at both the protein and the gene levels.Methods: Formalin-fixed, paraffin-embedded tissue samples from 30 invasive carcinomas, 7 benign lesions and two normal mammary glands were analyzed. Tumour features with prognostic value were recorded. The expression of protein HER-2 was analyzed by immunohistochemistry and the number of gene copies by means of DNA chromogenicin situhybridization.Results: Immunohistochemical HER-2 protein overexpression was found in 40% of feline mammary carcinomas, a percentage higher to that observed in human breast carcinoma. As in women, feline tumours with HER-2 protein overexpression had pathological features of high malignancy. However, amplification of HER-2 was detected in 16% of carcinomas with protein overexpression, a percentage much lower than that observed in their human counterpart.Conclusion: Feline mammary carcinoma would be a suitable natural model of that subset of human breast carcinomas with HER-2 protein overexpression without gene amplification.Keywords
This publication has 18 references indexed in Scilit:
- Immunohistochemical detection of HER‐2/neu expression in spontaneous feline mammary tumoursVeterinary and Comparative Oncology, 2005
- Overexpression of HER-2 in Feline Invasive Mammary Carcinomas: An Immunohistochemical Survey and Evaluation of Its Prognostic PotentialVeterinary Pathology, 2005
- Interlaboratory Comparison ofHER-2Oncogene Amplification as Detected by Chromogenic and Fluorescencein situHybridizationClinical Cancer Research, 2004
- Targeted Therapy in Breast CancerMolecular & Cellular Proteomics, 2004
- Oncogene HER-2 in Canine Mammary Gland CarcinomasBreast Cancer Research and Treatment, 2003
- Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors statusResearch in Veterinary Science, 2002
- Chromogenic in Situ HybridizationThe American Journal of Pathology, 2000
- Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay☆Domestic Animal Endocrinology, 2000
- Immunohistochemical Analysis of c-yes and c-erbB-2 Oncogene Products and p53 Tumor Suppressor Protein in Canine Mammary TumorsThe Journal of Veterinary Medical Science, 1999
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987